|
MCID: CHR139
|
Charcot-marie-tooth Disease Type 2c malady |
|
Sources: 30NIH Rare Diseases, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Charcot-Marie-Tooth disease (CMT) is a group of progressive disorders that affect the peripheral nerves and result in problems with movement and sensation. In CMT type 2 (CMT2), the motor system is more prominently involved than the sensory system, although both are involved. Individuals with this condition typically have slowly progressive weakness and atrophy of distal muscles in the feet and/or hands usually associated with depressed tendon reflexes and mild or no sensory loss. There is significant clinical overlap with CMT1. The subtypes of CMT2 are similar clinically and distinguished only by molecular genetic findings.
Charcot-Marie-Tooth disease type 2C (CMT2C) is a very rare form of CMT. Individuals with this condition may have diaphragm or vocal cord paresis in addition to the other problems associated with CMT. Mild sensory loss has also been noted in some individuals. CMT type 2C is caused by mutations in the TRPV4 gene on chromosome 12q24.30
MalaCards: Charcot-marie-tooth Disease Type 2c, also known as charcot-marie-tooth disease, axonal, type 2c, is related to scapuloperoneal spinal muscular atrophy. An important gene associated with Charcot-marie-tooth Disease Type 2c is TRPV4 (transient receptor potential cation channel, subfamily V, member 4). |
|
Sources: 43UMLS, 30NIH Rare Diseases See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials See all sources |
Approved drugs:Search CenterWatch for charcot-marie-tooth disease type 2c Drug clinical trials:Search ClinicalTrials for charcot-marie-tooth disease type 2c Search NIH Clinical Center for charcot-marie-tooth disease type 2c Search CenterWatch for charcot-marie-tooth disease type 2c |
|
|
|
|
|
|
|
Sources: 35PubMed See all sources |
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
